COMMUNIQUÉS West-GlobeNewswire
-
Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data
22/10/2026 -
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development
22/10/2026 -
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
22/10/2026 -
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
22/10/2026 -
Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
22/10/2026 -
VisCardia Announces Publication of RECOVER-HF Pilot Trial in JACC: Heart Failure
22/10/2026 -
CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
22/10/2026 -
FocalTherics™ to Announce Third Quarter 2026 Financial Results on November 5, 2026
22/10/2026 -
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
22/10/2026 -
Park Family & Cosmetic Dentistry Named Best Cosmetic Dentistry Practice in Naples, FL
22/10/2026 -
Delta Dental Foundation of North Carolina Commits $1 Million to Expand Oral Health Access Statewide
22/10/2026 -
Enlivex Announces 1-for-16 Reverse Share Split to be Effective October 27, 2026
22/10/2026 -
IQity Draws Strong Surgeon Interest at First Exhibition Debut, AAO 2026
22/10/2026 -
Nordic Naturals Experts Share the Four Questions Every Consumer Should Ask About Their Supplements
22/10/2026 -
Foundation for Sarcoidosis Research Welcomes Nine New Members to the FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA)
22/10/2026 -
A Race Against Blindness Celebrates Recent Fundraiser Winners During Blindness Awareness Month
22/10/2026 -
New Study Finds Pycnogenol® Improves Quality of Life and Symptoms Associated with Osteopenia and Osteoporosis in Post-Menopausal Women
22/10/2026 -
FEM By UPSA Appoints U.S. Advisors to Advance Science-Backed, Non-Hormonal Menopause Support
22/10/2026 -
Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers
22/10/2026
Pages